Yer­voy in­ven­tor's on­col­o­gy start­up Pi­o­nyr gets $62M for tu­mor-fight­ing tech

An on­col­o­gy com­pa­ny co-found­ed by one of the in­ven­tors of Yer­voy has closed a $62 mil­lion round to push its an­ti-tu­mor tech to­wards the clin­ic.

The start­up, called Pi­o­nyr Im­munother­a­peu­tics, is de­vel­op­ing an­ti­body ther­a­peu­tics that boost the body’s im­mune re­sponse at the site of the tu­mor. New En­ter­prise As­so­ciates led the round, along with new in­vestors Sofinno­va and Vi­da Ven­tures. Ex­ist­ing back­ers in­clud­ing Or­biMed joined the round.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER